Seroprevalence of HAV and HEV Infection in Patients Suspected Of Acute Viral Hepatitis

Seroprevalence of HAV and HEV Infection in Patients Suspected Of Acute Viral Hepatitis

Authors

  • Dr. Priyadarshini
  • Rajesh Katara
  • Minesh Vadsmiya
  • M.M. Vegad
  • Dr. Sarita
  • Dr. Suprabha

DOI:

https://doi.org/10.70284/njirm.v8i2.1211

Keywords:

HAV, HEV, Seroprevalence

Abstract

Background & objectives: HAV and HEV infections occur chiefly as a result of unhygienic conditions. This study was done to assess the seroprevalence of antibodies to HAV and HEV in patients of acute viral hepatitis. This study will also determine the disease distribution in different age groups. Methods: Serum samples of the patients presenting with jaundice were received in Serology laboratory, Department of Microbiology, B.J.M.C., of the patients admitted in Civil Hospital and outside from nearby PHCs and CHCs. These samples were tested for detection of IgM antibody against HEV and HAV by ELISA. Results and Interpretation: 1045 patients suspected of acute viral hepatitis were studied over a period of 3 months. The seropositivity of HAV was 49, out of which 35 were in the pediatric age group (71.4%). Seropositivity of HEV was 290, out of which 272 were adults (93.7%). Conclusion: HAV and HEV are notifiable diseases under IDSP. This study will help in determining the magnitude of public health problem posed by HAV and HEV. Also it will identify the age associated disease burden. Addressing the public health problems associated with the enteric transmission of viral hepatitis will require implementing stronger measures to prevent fecal contamination of food and water. [Priyadarshini NJIRM 2017; 8(2):88-90]

References

1. Jacobsen KH, Koopman JS. Declining hepatitis A seroprevalence: A global review and analysis. Epidemiol Infect 2004;132:1005-22.
2. World Health Organization, Hepatitis A vaccines: WHO position paper. Wkly Epidemiol Rec 2000;75:38-44
3. Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL. Harrison's Principles of Internal Medicine. 5 th ed.; 2001. p. 1694-710
4. Joon A, Rao P, Shenoy S M, Baliga S. Prevalence of Hepatitis A virus(HAV) and Hepatitis E virus(HEV) in the patients presenting with acute viral hepatits. Indian J Med Microbiol 2015;33,Suppl S1: 102-5
5. Al-Naaimi AS, Turky AM, Khaleel HA, Jalil RW, Mekhlef OA, Kareem SA, et al. Predicting acute viral hepatitis serum markers (A and E) in patients with suspected acute viral hepatitis attending primary health care centers in Baghdad: A one year cross-sectional study. Glob J Health Sci 2012;4:172-83.
6. Takahashi M, Nishizawa T, Gotanda Y, Tsuda F, Komatsu F, Kawabata T, et al. High prevalence of antibodies to hepatitis A and E viruses and viremia of hepatitis B, C, and D viruses among apparently healthy populations in Mongolia. Clin Diagn Lab Immunol 2004;11:392-8.

Downloads

Published

2018-02-01

How to Cite

Priyadarshini, D., Katara, R., Vadsmiya, M., Vegad, M., Sarita, D., & Suprabha, D. (2018). Seroprevalence of HAV and HEV Infection in Patients Suspected Of Acute Viral Hepatitis: Seroprevalence of HAV and HEV Infection in Patients Suspected Of Acute Viral Hepatitis. National Journal of Integrated Research in Medicine, 8(2), 88–90. https://doi.org/10.70284/njirm.v8i2.1211

Issue

Section

Original Articles

Most read articles by the same author(s)